Skip to main content
Clinical Trials/NCT02258113
NCT02258113
Unknown
Not Applicable

Measuring of Neuro-visual Functionality With New Human Visual System Device Ocusweep

Ocuspecto Oy1 site in 1 country600 target enrollmentNovember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Visual Impairment
Sponsor
Ocuspecto Oy
Enrollment
600
Locations
1
Primary Endpoint
Visual acuity
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to measure visual acuity, contrast sensitivity and visual field by SAP-method using a novel device Ocusweep compared to currently widely used methods. Addition to that, the aim is to validate a novel perimetry method (Visual Search Test, VST) which is based on reaction times in visual decision- making task, where the subject is allowed to move eyes and where the fixation is verified by the subject himself in contrast to standard automatic perimetry (SAP) where prolonged stationary fixation and external fixation monitoring apparatus is required. Reaction-time based visual field device Ocusweep is compared to generally used SAP methods. Those tests will be done for healthy volunteers and for persons with diagnosed eye or brain disease.

Ocusweep OcuRT vision based choice reaction time test is validated for test repeatability and compared to Trail Making Test (TMT), Useful Field of View (UFOV) and Vienna Test System (VTS) reaction time tests. To evaluate the ability to detect unreliable results, OcuRT test is also done under cognitive load and with instructions to cheat the test.

Registry
clinicaltrials.gov
Start Date
November 2014
End Date
December 31, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ocuspecto Oy
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers
  • Persons suffering diagnosed eye disease
  • Persons suffering diagnosed brain disease

Exclusion Criteria

  • No diabetes
  • Only one diagnosed disease

Outcomes

Primary Outcomes

Visual acuity

Time Frame: One visit per one patient (1h/visit)

Visual acuity is measured as logMAR unit at the one visit for each patient using a novel reaction-time based visual field device and comparable method.

Secondary Outcomes

  • Contrast sensitivity(One visit per one patient (1h/visit))
  • Reaction time visual field(One visit per one patient (1h/visit))
  • Vision based choice reaction time(One visit per one test subject (1h/visit))

Study Sites (1)

Loading locations...

Similar Trials